Gestational diabetes mellitus (GDM) is characterized by glucose intolerance with onset or first recognition during pregnancy.
Groundbreaking comparative study reveals best treatment for diabetes - Findings point to a paradigm shift in diabetes care, ...
Diabetes mellitus represents one of the foremost global health challenges, underpinned by a complex interplay of genetic predisposition, environmental influence and metabolic dysfunction. Contemporary ...
Ascletis Pharma has dosed the first participants in a US Phase II trial of ASC30, an oral small molecule glucagon-like ...
Vietnam Investment Review on MSN
Ascletis Begins Phase Two Diabetes Drug Trial
HONG KONG, Jan. 26, 2026 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that the first participants have been dosed in a U.S. 13-week Phase II study (NCT07321678) with ...
Introduction The increasing incidence of type 2 diabetes mellitus (T2DM) among women of reproductive age poses significant health risks for both mothers and their fetuses. Optimising blood glucose ...
Sciwind Biosciences Co., Ltd. ("Sciwind"), a biopharmaceutical company focused on the discovery and development of innovative therapies for metabolic diseases, announced today that China's National ...
Polyneuropathy occurs when multiple peripheral nerves malfunction throughout the body. Neuropathy is a common complication of type 2 diabetes mellitus (T2DM). Polyneuropathy occurs when there is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results